With Stake, Australia's leading investing platform, I'm excited to share the 12th episode of 'Going Public' - a monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.


In this episode of the Going Public series, Mark learns about the remarkable journey of Imugene Ltd (ASX: IMU), a clinical-stage immuno-oncology company revolutionising cancer treatment with cutting-edge immunotherapies. Join us as we explore how CEO Leslie Chong has helped transform Imugene from a single-technology startup to a biotech leader with five active clinical trials targeting various cancers. Discover the strategic moves that propelled the company's market cap from $10 million to $500 million and secured its place in the ASX Top 300. We'll also hear from Executive Chairman Paul Hopper, the mastermind behind the IMU listing and successful IPOs for Radiopharm (RAD) and Chimeric (CHM). This episode offers invaluable insights into the world of biotech, innovation, and the path to IPO success.


DISCLAIMER:

Views expressed are those of the individual only. This does not constitute financial advice. 

You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj. 

Join the Facebook Group.

Follow Mark Bouris on Instagram, LinkedIn & YouTube. 

See omnystudio.com/listener for privacy information.

With<a href="https://hellostake.com/" rel="noopener noreferrer" target="_blank"> Stake</a>, Australia's leading investing platform, I'm excited to share the 12th episode of 'Going Public' - a monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public. In this episode of the Going Public series, Mark learns about the remarkable journey of Imugene Ltd (ASX: IMU), a clinical-stage immuno-oncology company revolutionising cancer treatment with cutting-edge immunotherapies. Join us as we explore how CEO Leslie Chong has helped transform Imugene from a single-technology startup to a biotech leader with five active clinical trials targeting various cancers. Discover the strategic moves that propelled the company's market cap from $10 million to $500 million and secured its place in the ASX Top 300. We'll also hear from Executive Chairman Paul Hopper, the mastermind behind the IMU listing and successful IPOs for Radiopharm (RAD) and Chimeric (CHM). This episode offers invaluable insights into the world of biotech, innovation, and the path to IPO success. DISCLAIMER:Views expressed are those of the individual only. This does not constitute financial advice.&nbsp;You can subscribe to the newsletter here:&nbsp;<a href="https://lnkd.in/e7C8akgj" rel="noopener noreferrer" target="_blank">https://lnkd.in/e7C8akgj</a>.&nbsp;<a href="https://www.facebook.com/groups/mentormarkbouris/" rel="noopener noreferrer" target="_blank">Join the Facebook Group.</a>Follow Mark Bouris on&nbsp;<a href="https://www.instagram.com/mark_bouris/" rel="noopener noreferrer" target="_blank">Instagram</a>,&nbsp;<a href="https://au.linkedin.com/in/markbouris" rel="noopener noreferrer" target="_blank">LinkedIn</a>&nbsp;&amp;&nbsp;<a href="https://www.youtube.com/channel/UCPX01K1JgNS5pyzUtwtCtsQ" rel="noopener noreferrer" target="_blank">YouTube.</a>&nbsp;See <a href="https://omnystudio.com/listener" rel="noopener noreferrer" target="_blank">omnystudio.com/listener</a> for privacy information.<hr>

Mark Bouris speaks to business owners and entrepreneurs, finding out what makes them tick and their plans for growth. Some business owners are on the way up and enjoying new success, others are at a turning point. Mark digs into their stories and finds out why they set out to create their own path, their challenges and where they go from here. Based on his own personal experiences and learnings, he also passes on his own guidance on how to take their business to the next level.

Mark Bouris speaks to business owners and entrepreneurs, finding out what makes them tick and their plans for growth. Some business owners are on the way up and enjoying new success, others are at a turning point. Mark digs into their stories and finds out why they set out to create their own path, their challenges and where they go from here. Based on his own personal experiences and learnings, he also passes on his own guidance on how to take their business to the next level.

Mark Bouris speaks to business owners and entrepreneurs, finding out what makes them tick and their plans for growth.  Some business owners are on the way up and enjoying new success, others are at a turning point.  Mark digs into...

The Mentor with Mark Bouris

Developing Cancer Cures through the ASX | Going Public with Leslie Chong & Paul Hopper

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/f1e8dee1-adce-491a-a0a7-b30500515275/transcript

Advertisement